The purpose of this study was to elucidate the mechanism of natural uptake of nonfunctionalized quantum dots in comparison with microinjected quantum dots by focusing on their time-dependent accumulation and intracellular localization in different cell lines.
Introduction
An understanding of the fundamental interactions of nanoparticles with cells plays a central role in nanomedicine, as well as in terms of nanosafety issues. 1 Researchers have had considerable success in using nanoparticles and especially quantum dots for in vitro bioassays, labeling of fixed cells and tissue specimens, and selective imaging of membrane proteins in living cells. 2 On the other hand, the cytosol and various subcellular organelles house the most important biochemical processes involved in the functions of the cell. Effective delivery to the cytosol enhances the potency of anticancer drugs, stimulates the adaptive immune response, and is crucial for gene therapies involving delivery of DNA or RNA. 3 However, only limited progress has been made in developing quantum dot probes to perform imaging inside living cells. 4 A major problem is the lack of efficient methods for delivering monodispersed quantum dots into the cytoplasm of living cells. 5, 6 The first paper on accumulation of quantum dots in cells was published more than a decade ago, 7, 8 but the question of how quantum dots enter different cells is still open.
Methods used to date for intracellular delivery of quantum dots and a variety of other nanoparticles can be derived from three strategies, 6 ie: passive delivery, which relies on the inherent physicochemical properties of the quantum dot itself (coating, structure, and charge) to mediate cellular internalization; facilitated delivery, which typically involves marking the quantum dot surface with a functional molecule that can be biological in nature (such as a peptide or a protein) or with other functional chemicals, such as polymers or drugs; and direct delivery, which involves physical techniques, such as microinjection and electroporation. Intracellular uptake (passive or facilitated delivery) of quantum dots or other particles may occur via various endocytotic mechanisms, 9 passive permeation, and adsorptive endocytosis. 10 It is clear that accumulation of quantum dots in cells is a complicated issue because numerous intrinsic factors influence the uptake and intracellular transport of nanoparticles, including size, surface charge, and structure of a coating. 1, 11, 12 Analysis of results presented in the literature reveals a very wide range of values for quantum dot internalization parameters, in particular, uptake time and intracellular localization. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] This could be due to time-dependent changes in accumulation and intracellular distribution of quantum dots taking place even in a single cell line. The interpretation of results is even more complicated in the case of in vivo studies where the quantum dots would be internalized by different types of cells. 13 A major challenge in nanomaterial science is to develop approaches ensuring that, when administered in vivo, nanoparticles can be targeted to their designated site of action. However, nanoparticles in a biological environment are quickly coated by serum proteins, which affect their cellular uptake, transportation, and fate, 25 including the cellular response, and can have important consequences for therapeutic efficacy. 26 It has been reported that reduction of protein adsorption in vivo helps to avoid the reticuloendothelial system. 27 There is still a lot to learn about cellular uptake and intracellular transport of nanoparticles in order to interpret data from in vitro studies unambiguously, to improve their in vivo use, and to facilitate the rational design of functionalized quantum dots. 28 Therefore, this study was dedicated to expanding the understanding of natural quantum dot uptake by analysis of differences in accumulation between several cell lines, over wide time intervals. The focus was on intracellular localization and transportation of one type of nonfunctionalized quantum dot bearing a negatively charged coating, observing its fate after incubation in complete medium or serum-free medium, and after microinjection.
Materials and methods

Cell cultures
An immortalized mouse embryonic fibroblast cell line (NIH3T3, average doubling time 22 hours), 29 a human breast adenocarcinoma cell line (MCF-7, average doubling time 29 hours), 29 and a human hepatocellular carcinoma-derived cell line (HepG2, average doubling time 34 hours) 29 were cultured in the presence of CO 2 (5% v/v) at 37°C in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY) supplemented with fetal bovine serum (10% v/v), 0.1% antibiotics (stock, 1000 U/mL penicillin, 1000 µg/mL streptomycin) to obtain approximately 60% confluence. For all experiments on uptake of quantum dots, the cells were seeded in 30 mm Petri dishes at a density of 40% confluence in growth medium and allowed to grow for one day. The final 10 nM concentration of quantum dots was used in the incubation medium for all experiments.
Quantum dots
Commercially available CdSe/ZnS quantum dots with a 5.2 nm core 30 eFluor™ 625 NC (Carboxyl), (Cat No 94-6364, eBioscience™ eBioscience, Inc.San Diego, CA, USA) (recommended range for excitation 350-610 nm and an emission peak at 625 nm), rendered water-dispersible with a patented poly ethylene glycol-lipid layer and carboxyl groups (total hydrodynamic radius 13-18 nm), delivered as a 10 µM aqueous solution, were used as model nanoparticles. The superficial carboxyl groups (pK a = 1.8-2.5) on the quantum dots remain deprotonated at physiological pH and form negatively charged COO -residuals.
Confocal microscopy
Living cells were incubated in full or serum-free medium for different periods and then imaged using a confocal Steady-state fluorescence spectroscopy of intracellular uptake dynamics
The cells were incubated in Petri dishes with 10 nM of quantum dots in a serum-free medium over a time course ranging from 15 minutes to 24 hours and were kept in the incubator (37°C, 5% CO 2 ) or on ice (4°C) to study the effect of temperature. After the appropriate time had passed, the cells were washed three times with phosphatebuffered saline (pH 7.4) and detached from their plates by trypsinization. After trypsinization, the cells were collected, centrifuged (at 500 g for 2 minutes) and resuspended in a final phosphate-buffered saline volume of 1.5 mL. The cell concentration was determined by counting the number of cells per milliliter using a hemacytometer. Quantitative analysis of quantum dot uptake into living cells was performed using a steady-state Fluorescence Lifetime spectrometer (FLS920, Edinburgh Instruments, Livingston, UK). During spectroscopic measurements, the temperature was maintained at 37°C in a temperature-controlled cuvette chamber. The cell suspension was placed in a 1 cm path length cuvette (Hellma Optics, Jena, Germany) and stirred constantly with a micro stir bar to ensure a uniform concentration of cells and to prevent sedimentation. Photoluminescence was excited at 405 nm, and excitation and emission slits were set for 5 nm. Autofluorescence of suspended cells was measured in control samples. Statistical analyses were performed using the one-way analysis of variance test, and differences were considered to be statistically significant at P , 0.05. The data used for analysis were representative results or the means of at least three independent experiments ± the standard error of the mean.
Microinjection
Solution for injection was prepared by diluting 0.5 µL of quantum dots from a stock solution in 9.5 µL of phosphate-buffered saline. A microinjector (Eppendorf FemtoJet and CellTram Air, Hamburg, Germany) was used for direct injection of the quantum dots into the cytoplasm (injection pressure 200 hPa, rate 500 µm/s). Confocal fluorescent images of the cells were taken immediately after injection and incubation for 24 hours (37°C, 5% CO 2 ).
Transfection with eGFP plasmid
Temporal transfection of NIH3T3 with enhanced green fluorescent protein (eGFP) plasmid followed the standard protocol for transfection of adherent cells. The following solutions were prepared separately: solution A, eGFP plasmid in 50 µL of Dulbecco's modified Eagle's medium, and solution B, 1.5 µg of Metafectene ® Pro (Biontex, Martinstried, Germany) in 50 µL of Dulbecco's modified Eagle's medium free of antibiotics. Mixed solutions were kept at room temperature for 20 minutes. The plasmid-Merafectene Pro complexes formed were added to the plates containing NIH3T3 cells. After 6 hours, the transfection mixture was removed and replaced with fresh Dulbecco's modified Eagle's medium supplemented with fetal bovine serum (10% v/v) and 0.1% antibiotics (stock, 1000 U/mL penicillin, 1000 µg/mL streptomycin), and the plates were returned to the CO 2 incubator for 48 hours. Next, 3 µL of quantum dot suspension was added to the medium on the plates, and the NIH3T3 cells were kept in the CO 2 incubator until analysis.
Intracellular localization of quantum dots using Lysotracker ® NIH3T3 cells in complete and serum-free medium were treated with 10 nM quantum dots for 24 hours in a CO 2 incubator at 37°C, then washed three times and additionally stained for 2 hours with 50 nM of lysosome dye (Lysotracker green, Invitrogen, Carlsbad, CA). Confocal fluorescence images were recorded separately in each fluorescence channel and merged afterwards.
Results
Natural uptake of quantum dots
Uptake of quantum dots into NIH3T3 cells was markedly decreased at the lower temperature, indicating that the process is energy-dependent ( Figure 1 ). The anticipated elevation of cellular uptake of carboxyl quantum dots at a temperature of 37°C also implied the active nature of the accumulation mechanism dominating over internalization of small-sized molecules via passive diffusion. 31 The uptake kinetics drawn on the basis of changes in red photoluminescence intensity revealed an S-shaped (plateau, submit your manuscript | www.dovepress.com Dovepress Dovepress growth, and saturation stages) dependence of accumulation of carboxyl-coated quantum dots in different cell lines (NIH3T3, HepG2, and MCF-7) on duration of incubation at 37°C (Figure 2A ), but the stages were of different timing for each of the cell lines ( Figure 2B ). The photoluminescence intensity of the carboxyl-coated quantum dots associated with NIH3T3 and MCF-7 cells increased with time and started to saturate after 6 hours. The photoluminescence intensity in the case of HepG2 cells remained very weak and started to increase only after 30 hours. Confocal fluorescence images taken immediately, and at 0.5, 1, 6, 24, and 48 hours after incubation of the cells with quantum dots ( Figure 2C -F and Supplementary data, Figure 1 ) show evolution of the distribution pattern and transport vesicles of carboxyl-coated quantum dots in the cells: phase 1, adherence to the cell membrane (t inc 30-60 minutes, Figure 2C ); phase 2, formation of granulated clusters spreading in the cytoplasm (t inc 0.5-6 hours, Figure 2D ); phase 3, localization of granulated clusters in the perinuclear region (t inc 6-24 hours, Figure 2E) ; and phase 4, formation of multivesicular body-like structures and their redistribution in the cytoplasm (t inc . 24 hours, Figure 2F ). The granulated pattern of the red photoluminescence of quantum dots present inside NIH3T3 cells (assigned to phase 2, Figure 2D and Figure 3A ), indicates Figure 3A) . Two different vesicle types of the same size (about 1 µm in diameter) were observed during phase 3, ie, those fully filled with quantum dots ( Figure 3B ) and the ring-like vesicles with quantum dots being attached to the inner surface without distribution throughout the cytosol ( Figure 3C ). The largest vesicles (approximately 5-8 µm) observed during phase 4 were revealed to be multivesicular body-like structures, being formed of many small vesicles completely filled with quantum dots and packed into a single large vesicle ( Figure 3D ).
Direct delivery of quantum dots
The comparative study of the fate of quantum dots entering cells via passive diffusion was performed by simulating the direct delivery approach. A strikingly contrasting distribution pattern of quantum dot photoluminescence was observed in cells after intracellular microinjection ( Figure 4A and B versus C). The injected quantum dots were instantly well Figure 4A ). Formation of quantum dot-containing vesicular structures was not observed afterwards either ( Figure 4B ). In fact, such distribution of injected quantum dots was found to be similar to the intracellular distribution pattern of quantum dot photoluminescence observed in a cell with a damaged plasma membrane during incubation with quantum dots ( Figure 4D ).
Fate of intracellular quantum dots
The observed time-dependent restructuring of quantum dot-containing vesicles during natural uptake and accumulation (changes in size of vesicles and formation of multivesicular body-like structures) prompted us to investigate the intracellular migration of quantum dots, possible fusion of quantum dot-containing vesicles, and likelihood of quantum dots becoming entrapped inside vesicles escaping into the cytosol. eGFP-transfected cells have been used to clarify those processes. Transfection in itself had no influence on the phases of quantum dot accumulation in cells or on formation and reshaping of red-luminescing endosomes ( Figure 5B ). Dark and red-luminescing endosomes were detected on the background of the green fluorescence in eGFP transfected cells after 24 hours of keeping them in a growth medium with quantum dots ( Figure 5A ). Close inspection of the vesicles formed revealed small (about 0.5 µm) vesicles inside larger (about 1.5 µm) dark endosomes ( Figure 5C ), implying possible fusion of endosomes containing quantum dots with endosomes without quantum dots. However, no trace of red photoluminescence of quantum dots dispersed across the entire cytosol was detected ( Figure 5B and C) , as in the case Figure 4A and B) , and no appearance of a yellow color caused by colocalization of red quantum dots with green eGFP was found. The presence or absence of protein in the growth medium was found to have no influence on these observations. Additional investigation of the role of incubation conditions in the fate of quantum dots inside NIH3T3 cells was performed using a fluorescent cell-permeant acidic organelleselective marker, ie, Lysotracker green. The Lysotracker probes, which comprise a fluorophore linked with a weak base that is only partially protonated at neutral pH, freely penetrate cell membranes and are typically used to mark organelles (lysosomes) at acidic pH. Because the same four morphological phases were observed when incubating the cells with quantum dots in complete or serum-free medium, Lysotracker was used to identify the ability of quantum dots to reach the lysosomal compartments.
Confocal microscopy of NIH3T3 cells after 24 hours of incubation showed that that fluorescence images of quantum dot-containing vesicles and Lysotracker green-stained organelles were matched in complete medium ( Figure 6A-C) , but quantum dots and Lysotracker were not colocalized in fluorescent images taken in serum-free medium. Quantum dots were observed in Lysotracker-negative vesicles with, most likely, higher internal pH ( Figure 6E-G) . The Lysotracker-positive compartments without quantum dots were still observed throughout the cytoplasm of the cells ( Figure 6E ).
It was also of interest to determine whether cells have removal pathways for quantum dots once they have been taken up or whether accumulation of quantum dots in the lysosomes could lead to their degradation. However, extracellular release of the vesicle contents was never observed in any tested cell line (for NIH3T3 cells, see Supplementary data, Figure 2 ). It is of note that all the treated cells remained viable for at least 96 hours (for NIH3T3 cells see Supplementary data, Figure 3 ) without any signs of quantum dot-induced toxicity. Further, no traces of quantum dots were found in the nucleus (Supplementary video available at http://youtu.be/-Vma-7sGw0Y ).
Discussion
The effect of temperature on the accumulation dynamics of nontargeted quantum dots indicates that quantum dots are internalized by an energy-requiring membrane transport process, presumably an energy-requiring endocytotic mechanism which is not effective at 4°C. 32, 33 Cell membrane lipids have a tendency to form a "gel-like" phase, which inhibits both natural uptake and passive diffusion of nanoparticles into the cell. 34 It is known that diffusion through the lipid bilayer is characterized as an instantaneous linear 35 and nonsaturable process. 31 However, with increasing temperature, the plateau and saturation stages observed in the process of accumulation of nontargeted quantum dots indicates that passive diffusion through the intact cell plasma membrane is negligible, even if the size of biologically inert quantum dots implies that they could enter the cell via pore defects. 36 Despite time-related differences, the distribution of nontargeted quantum dots followed similar accumulation stages and morphological phases in the different cell lines (NIH3T3, HepG2 and MCF-7). It is worth mentioning that the morphological phases of accumulation of quantum dots were not equally clearly expressed in the cell lines studied. The main reasons could be the different physiology of the cell lines and cell type-specific surface receptors 37 ( Figure 2B , Supplementary data, Figure 1E-H) . The observed variations in timing of uptake between the cell lines (Figure 2A and B) may also be influenced by cell-related specificity of internalization mechanisms for quantum dots. 
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It should be noted that phases 1 and 2 of quantum dot distribution in the cells were found earlier in the studies reported by Hoshino et al, 16 Clift et al, 20 and Jiang et al, 19 Kelf et al, 14 Williams et al, 15 and Corsi et al, 17 which showed formation of vesicular structures spread in the cytoplasm corresponding to phase 2. Phase 3, ie, localization of vesicular structures in the perinuclear region, was described by Zhang et al 22 and Xiao et al, 23 and reviewed by Parak et al. 33 Phase 4 resembles the data on formation of multivesicular body-like structures and their redistribution in cytoplasm presented by Yuan et al 18 and Jiang et al. 19 However, there has been no presentation of an overall picture illustrating the time-dependent nature of natural uptake and distribution of nontargeted negatively charged quantum dots in living cells.
On the basis of the results presented here, we suggest a scheme for a potential natural mechanism of intracellular uptake of nontargeted quantum dots as illustrated in Figure 7 and comprised of the four major phases described above. Internalization of quantum dots can occur via several possible primary steps, ie, adsorption of proteins from the culture medium onto the surface of the quantum dots, followed by their internalization via receptor-mediated pathways 14 or nonspecific binding and clustering of the nanoparticles near cationic sites on the plasma membrane, triggering receptors and inducing subsequent endocytosis 12 ( Figure 7) . The uptake process begins with adherence of quantum dots to cell surface receptors present in the plasma membrane. Following energy-dependent internalization during phase 1, this complex then enters the cells in the form of cargo located inside receptor-coated structures called endocytotic vesicles. Adherence of quantum dots onto the membrane being observed only during phase 1 ( Figure 2C-F) together with a certain specificity in quantum dot uptake ( Figure 5C ), as well as its saturation in time ( Figure 2B ), which cannot be explained by doubling time or cell division given that the saturation stage was observed not later than 6 hours after incubation and sufficient amounts of quantum dots were present in the medium, indicate a gradual interruption of the receptor sorting and recycling steps. To sustain internalization, the receptors must be recycled back to the external membrane, which takes time and lengthens the internalization rate. Consequently, the reduced number of available receptors that a nanoparticle triggers when it adheres to the membrane can also play a suppressive role during the process of internalization followed by translocation of a loaded vesicle inside the cell. 38 Variations in the amount of plasma membrane receptors between the different cell lines could contribute to the time-related differences observed in the uptake phases of quantum dots.
Independently of the mode of entry at phase 2, endocytosed cargo is usually delivered to early endosomes. 39 This process is followed by their controlled migration (against a concentration gradient), fusion, and localization in the perinuclear region (phase 3), close to the Golgi complex and microtubule organizing center. 40, 41 Afterwards, these early endosomes mature into late endosomes (phase 4), which spread into the cytoplasm and Figure 3 ). According to the observed sizes and types of quantum dot-containing vesicles, they can be categorized into three types: endocytotic vesicles, (up to 1 µm in diameter, formation time 15-60 minutes), 42 which merge into larger vesicles by homotypic fusion; early endosomes (up to 5 µm in diameter, formation time more than one hour), which are mainly spherical; 43 and late endosomes/multivesicular bodylike structures with the presence of intraluminal vesicles. 44 Direct delivery of quantum dots into cells is very limited in its throughput and is not suited to manipulation of tens to hundreds of cells at a time, but is valuable for gaining new research insights. This alternative technique allows delivery of very small sample volumes (usually femtoliters) directly into the cytoplasm of individual cells, avoiding reaction with the plasma membrane, which is the main barrier and cause of intracellular vesicle formation during natural uptake. In contrast with natural uptake, microinjected quantum dots underwent no changes and remained uniformly distributed in Moreover, experiments with eGFP transfected cells confirmed the suggestion that quantum dots entrapped inside vesicles during endocytosis could not escape to the cytosol. Vesicle fusion evident in phase 4 ( Figure 2C ) and in the experiments on eGFP transfected cells ( Figure 5C ), together with the effect of temperature on intracellular quantum dot accumulation, clearly demonstrate that natural uptake of quantum dots is impossible without endocytosis. Moreover, transfer of quantum dots from endocytotic vesicles into the cytosol and vice versa is limited. The three accumulation stages and four phases of intracellular distribution of quantum dots were identified by confocal microscopy independently of the content of the medium, but Lysotracker experiments revealed differences in the fate of the quantum dots. Examination of the intracellular trafficking of quantum dots entrapped inside the vesicles revealed that the fate of quantum dots was highly dependent on the content of the incubation medium, affecting the primary steps of uptake, ie, quantum dots incubated with cells in serum-free medium did not fuse with lysosomes ( Figure 6E-G) , while quantum dots incubated with cells in complete medium were fully colocalized with lysosomes ( Figure 6A-C) . Partial colocalization was reported in serum-free medium by Barua et al, 13 with a significant fraction of quantum dots being localized in Lysotracker-negative vesicles, but the nature of these compartments was not identified. Furthermore, it has been presumed that the acidic nature of the cargo present in these vesicles, ie, carboxylated quantum dots, could contribute to acidification of these vesicles, which in turn targets them for strong staining with the reagent. Some cellular localization studies performed using nonacidic nanoparticles 45, 46 showed that these nanoparticles did not colocalize with either early endosomes or lysosomes. Therefore, the effect of the quantum dot coating on intravesicular pH must be taken into account for interpretation of the results of intracellular localization.
The observed saturation of accumulation during incubation in full medium most likely occurred due to the protective effect of adherent proteins on the surface of the quantum dots ( Figure 6D ), providing them with sufficient stabilization. 47 Otherwise, upon entry into lysosomes, quantum dots would have been degraded, causing inactivation of cells (contrary to the observed viability of cells even after 96 hours of incubation with quantum dots, Supplementary data, Figure 3 ), because quantum dots are not stable in an acidic environment 48, 49 and the core/shell elements are highly toxic to cells. The fate of highly stable, long-lived endocytotic structures is the focus of current discussion 50, 51 and needs further investigation.
Differences in colocalization with a lysosome marker observed between nontargeted (protein-free) quantum dots ( Figure 6H ) and quantum dots possessing a protein corona 1 ( Figure 6D ) imply that these quantum dots are, most likely, recognized differently by the cells and internalized by different pathways (Figure 7 ). Also, it should be noted that uptake of quantum dots does not depend only on their intrinsic properties, such as core material, shape, size, or charge, which are mostly reviewed in ongoing studies. The uptake, internalization pathway, and fate of the same quantum dots are also dependent on external factors (eg, content of the incubation medium), highlighting the variability of localization of the same material at the whole body, organ system, tissue, cell, and organelle levels, depending on the identity, organization, and residence time of the protein corona at the nanoparticle surface and emphasizing the need to develop "cloaked" nanoparticles as long-circulating carriers for improved applicability in vivo.
Conclusion
Nontargeted negatively charged quantum dots were internalized by NIH3T3 cells via an energy-requiring endocytotic mechanism. The natural mechanism of intracellular uptake of nontargeted quantum dots is comprised of three major stages, ie, a plateau stage, growth stage, and saturation stage, accompanied with four morphological phases: adherence to the cell membrane; formation of granulated clusters spread throughout the cytoplasm; localization of granulated clusters in a perinuclear region; and formation of multivesicular body-like structures and their redistribution in the cytoplasm (Figures 2 and 7) . The three stages were observed in all cell lines studied, but varied in the timing and amount of quantum dots accumulated for each cell line (Figure 2 , Supplementary data, Figure 1) .
Unlike with natural uptake, the injected quantum dots were diffusely spread inside the cells throughout the cytosol without any specificity (Figure 4 ). In addition, observations of intracellular trafficking of the quantum dots after the microinjection procedure together with the experiments on eGFP-transfected cells clearly demonstrate that the quantum dots can neither enter into vesicles from the cytosol nor escape into the cytosol, being entrapped inside the vesicles during endocytosis ( Figure 5) .
The natural uptake of nontargeted quantum dots bearing a negative coating thus revealed some characteristic features, ie, not only its commonly accepted dependence on the submit your manuscript | www.dovepress.com Dovepress Dovepress intrinsic properties of nanoparticles, but also the properties of the external medium, low rate of accumulation, breakage of the quantum dot transportation route at phase 3, formation of ring-like shaped luminescence of vesicles with quantum dots present on membranes, and formation of long-lived multivesicular body-like structures.
All these findings provide an overall framework for future studies to clarify fully the kinetic processes involved in uptake of quantum dots by different cell types. Fundamental questions, such as the role of the protein corona in directing uptake and the internal structure of quantum dots containing vesicles regulating their intracellular localization, need further investigation for future development of in vivo applications, because endocytosis is the primary route of cellular uptake for small drugs and macromolecular therapeutics. At this present time, we believe that nontargeted quantum dots can be used for nonspecific imaging of cells but not for drug transfer because they are trapped into vesicles during uptake. For medical use, it would be necessary to tailor nanoparticles in a way that would prevent entrapment in the vesicles or to use artificial injection methods (such as electroporation, sonoporation, or photochemical internalization), enabling them to enter the cytoplasm, avoiding the first mechanical barrier, ie, the plasma membrane, and reach intracellular targets. 
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